Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,526,513,683
-$711,095,852 QoQ
Shares Held
48,197,514
-17.8% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#2
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dodge & Cox holds $7,907,700,561 across 13 Drug Manufacturers - General names. GSK ranks #2 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
23,677,567 | $2,991,423,814 | |
| 2 | GSK |
GSK plc
This page
|
48,197,514 | $2,526,513,683 | |
| 3 | SNY |
Sanofi
|
28,088,274 | $1,198,245,768 | |
| 4 | NVO |
Novo Nordisk A S
|
20,397,110 | $977,837,453 | |
| 5 | NVS |
Novartis AG
|
759,373 | $119,008,936 | |
| 6 | LLY |
ELI LILLY & Co
|
41,258 | $49,486,087 | |
| 7 | MRK |
Merck & Co., Inc.
|
135,750 | $17,443,875 | |
| 8 | AZN |
Astrazeneca PLC
|
55,949 | $10,609,049 |
All Filings in GSK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,082,240,344 | 173,259,068 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $2,526,513,683 | 48,197,514 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,237,609,535 | 58,662,974 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,360,121,199 | 68,517,969 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,383,905,159 | 78,403,734 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,024,302,169 | 78,757,869 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,046,972,010 | 78,651,833 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,314,671,643 | 68,440,912 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,783,403,223 | 68,087,163 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,630,979,813 | 68,337,138 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,952,127,143 | 68,862,308 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,558,132,948 | 69,026,793 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $2,511,442,883 | 69,281,183 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,480,945,591 | 69,611,268 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,480,177,479 | 69,707,068 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,281,743,933 | 64,932,952 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,724,126,796 | 58,583,989 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,169,735,403 | 74,242,722 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,663,579,347 | 85,750,621 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,828,756,296 | 88,519,444 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,298,591,735 | 88,017,914 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,445,050,099 | 88,209,189 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,078,571,500 | 87,947,245 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,271,568,005 | 62,935,758 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,661,303,257 | 45,000,656 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,661,193,483 | 41,522,745 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,636,476,858 | 44,035,690 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||